FASSI, ENRICO MARIO ALESSANDRO
FASSI, ENRICO MARIO ALESSANDRO
Dipartimento di Scienze Farmaceutiche
Insights into the catalytic mechanism of formate dehydrogenases from different microbial sources
2026 L. Legnani, M. Gargiulo, E. Lio, E.M.A. Fassi, G. Grazioso, M.A. Chiacchio, B. Binay, S. Brocca, F. Secundo
Targeting Pseudomonas aeruginosa LecB with Photoswitchable Glycomimetic Ligands
2026 A. Colleoni, S. Bhattacharya, G. Tempra, E.M.A. Fassi, M. De Amici, G. Grazioso, R. Castagna, E. Parisini, C. Matera
PCSK9 inhibitors: an updated patent review 2024–2025
2026 E.M.A. Fassi, M. Albani, L. D'Adduzio, E.G. Milano, C. Lammi, G. Grazioso
Breakable Organosilica Nanocapsules for the Intracellular Delivery of a Peptide With Promising Anti‐Breast Cancer Activity
2026 S. Mathlouthi, A. Ajò, E.M.A. Fassi, A. Cagnotto, A. Fragassi, C. Pesce, M. Garofalo, L. De Cola, G. Grazioso
Design, synthesis and characterization of novel potential TAU-degraders
2026 G. Tempra, E.M.A. Fassi, G. Grazioso, P. Seneci, D. Passarella
Modulatori Fotosensibili dell’adesione batterica: una nuova strategia per ridurre l’antibiotico-resistenza
2025 A. Colleoni, G. Tempra, S. Bhattacharya, E.M.A. Fassi, M. De Amici, G. Grazioso, R. Castagna, E. Parisini, C. Matera
Spatiotemporal Control of Bacterial Adhesion via Light-Responsive Modulators
2025 A. Colleoni, G. Tempra, S. Bhattacharya, E.M.A. Fassi, M. De Amici, G. Grazioso, R. Castagna, E. Parisini, C. Matera
Design and synthesis of CD70 inhibitors: a potential way for the treatment of ulcerative colitis
2025 M. Galli, A. Silvani, G. Grazioso, E.G. Milano, E.M.A. Fassi, M. Bramuzzo, A. Muzzo, G. Stocco, M. Lucafò
Nature‐Inspired Compounds Targeting Escherichia coli WrbA as Biofilm‐Modulating Agents: Computational Design, Synthesis, and Biological Evaluation
2025 M. Mori, E.M.A. Fassi, F. Villa, E.G. Milano, F. Forlani, F. Cappitelli, A. Ratti, F. Meneghetti, G. Roda, G. Grazioso, S. Villa
Light-Responsive Modulators of Bacterial Cell Adhesion Proteins: a Novel Strategy against AMR?
2025 A. Colleoni, G. Tempra, S. Bhattacharya, E.M.A. Fassi, M. De Amici, G. Grazioso, R. Castagna, E. Parisini, C. Matera
Enhancing the activity of γ-hydroxy lactone derivatives as innovative peroxisome proliferator-activated receptor γ non-agonists inhibiting cyclin-dependent kinase 5-mediated phosphorylation
2025 G. Cazzaniga, D. Capelli, R. Montanari, E.M.A. Fassi, G. Grazioso, A. Tresoldi, F. Rinaldi, E. Calleri, I. Bassanini, S. Romeo, M. Garofalo, M. Mori, F. Meneghetti, S. Villa
Insights on Zosteric Acid Analogues Activity Against Candida albicans Biofilm Formation
2025 C. Catto', E.M.A. Fassi, G. Grazioso, A. Gelain, S. Villa, F. Cappitelli
FYCO1 Peptide Analogs: Design and Characterization of Autophagy Inhibitors as Co-Adjuvants in Taxane Chemotherapy of Prostate Cancer
2025 E.M.A. Fassi, R.M. Moretti, M. Montagnani Marelli, M. Garofalo, A. Gori, C. Pesce, M. Albani, E.G. Milano, J. Sgrignani, A. Cavalli, G. Grazioso
Support Vector Machine Identification of Small Molecule Binders to an Understudied Allosteric Site of SARS‐CoV‐2 Mpro for Next‐Generation PROTAC‐Based Therapeutics
2025 E.M.A. Fassi, N. Mekni, M. Albani, S. Maehrlein, A.C. Weldert, T. Schirmeister, T. Langer, G. Grazioso
A potent nonapeptide inhibitor for the CXCL12/HMGB1 heterocomplex: A computational and experimental approach
2025 E.M.A. Fassi, E. Pirani, V. Cecchinato, A. Cavalli, G. Roda, M. Uguccioni, J. Sgrignani, G. Grazioso
Towards a safe treatment of Insulin Resistance: γ-hydroxy lactone-based derivatives as PPARγ non-agonists
2024 G. Cazzaniga, M. Mori, D. Capelli, R. Montanari, A. Laghezza, F. Loiodice, E.M.A. Fassi, G. Grazioso, F. Meneghetti, S. Villa
High‐throughput peptide array analysis and computational techniques for serological profiling of flavivirus infections: Implications for diagnostics and vaccine development
2024 M. Bombaci, E.M.A. Fassi, A. Gobbini, D. Mileto, I. Cassaniti, E. Pesce, E. Casali, A. Mancon, J. Sammartino, A. Ferrari, E. Percivalle, R. Grande, E. Marchisio, M.R. Gismondo, S. Abrignani, F. Baldanti, G. Colombo, R. Grifantini
PCSK9 inhibitors: a patent review 2018-2023
2024 E.M.A. Fassi, A. Citarella, M. Albani, E.G. Milano, L. Legnani, C. Lammi, A. Silvani, G. Grazioso
Novel Non-peptide Uracil-derived Human Gonadotropin-Releasing Hormone Receptor Antagonists
2024 S. Ciceri, E.M.A. Fassi, V. Vezzoli, M. Bonomi, D. Colombo, P. Ferraboschi, G. Grazioso, P. Grisenti, S. Villa, C. Castellano, F. Meneghetti
Computational Design of Novel Cyclic Peptides Endowed with Autophagy-Inhibiting Activity on Cancer Cell Lines
2024 M. Albani, E.M.A. Fassi, R.M. Moretti, M. Garofalo, M. Montagnani Marelli, G. Roda, J. Sgrignani, A. Cavalli, G. Grazioso